Zeyang Ding

2.7k citations

92 papers · 1.8k indexed · 1 hit paper · h-index 28

Impact in

Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis

Papers in ⓘ

Molecular Biology 45
- RNA modifications and cancer 14
- TGF-β signaling in diseases 10
- Epigenetics and DNA Methylation 7
Oncology 20
- Cancer Immunotherapy and Biomarkers 7
- Pancreatic and Hepatic Oncology Research 7

Co-authors: Bixiang Zhang (40 shared papers)Xiaoping Chen (28 shared papers)Huifang Liang (33 shared papers)Ganxun Li (24 shared papers)Weixun Chen (9 shared papers)Guan-nan Jin (19 shared papers)Zhao Huang (11 shared papers)Jia Song (11 shared papers)
Journals: Aging (5 papers)Hepatology (4 papers)Frontiers in Immunology (3 papers)Journal of Cellular Physiology (3 papers)ACS Nano (3 papers)
Partner nations: China United States Hong Kong

In The Last Decade

Zeyang Ding

83 papers receiving 1.8k citations

Hit Papers

align trajectories log scale

Cancer stem cells and niches: challenges in immunotherapy resistance 2025 · 32 citations

Peers

Countries citing papers authored by Zeyang Ding

Since Specialization

Citations

This map shows the geographic impact of Zeyang Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zeyang Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zeyang Ding more than expected).

Fields of papers citing papers by Zeyang Ding

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zeyang Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zeyang Ding. The network helps show where Zeyang Ding may publish in the future.

Co-authors

The 25 scholars most cited alongside Zeyang Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Zeyang Ding Line = papers co-authored together Zeyang Ding links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 92 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Reduced expression of transcriptional intermediary factor 1 gamma promotes metastasis and indicates poor prognosis of hepatocellular carcinoma Hepatology ·Zeyang Ding, Guan-nan Jin, Wei Wang, Weixun Chen, Yanhui Wu, Xi Ai, Lin Chen, Wanguang Zhang, Huifang Liang, Arian Laurence, Ming‐Zhi Zhang, Pran K. Datta, Bixiang Zhang, Xiaoping Chen	2014	93
2	Hyperbaric Oxygen Boosts PD‐1 Antibody Delivery and T Cell Infiltration for Augmented Immune Responses Against Solid Tumors Advanced Science ·Xin Liu, Ningbing Ye, Sha Liu, Jiankun Guan, Qingyuan Deng, Zhijie Zhang, Chen Xiao, Zeyang Ding, Bi‐xiang Zhang, Xiaoping Chen, Zifu Li, Xiangliang Yang	2021	73
3	Association between high visceral fat area and postoperative complications in patients with Crohn's disease following primary surgery Colorectal Disease ·Zeyang Ding, Xian Wu, Erick M. Remer, Lei Lian, Luca Stocchi, Y. Li, Arthur J. McCullough, Feza H. Remzi, Bo Shen	2015	71
4	The 14-3-3σ protein promotes HCC anoikis resistance by inhibiting EGFR degradation and thereby activating the EGFR-dependent ERK1/2 signaling pathway Theranostics ·Jia Song, Yachong Liu, Furong Liu, Lu Zhang, Ganxun Li, Chaoyi Yuan, Chengpeng Yu, Xun Lu, Qiumeng Liu, Xiaoping Chen, Huifang Liang, Zeyang Ding, Bixiang Zhang	2020	63
5	Transforming growth factor β induces expression of connective tissue growth factor in hepatic progenitor cells through Smad independent signaling Cellular Signalling ·Zeyang Ding, Guan-nan Jin, Huifang Liang, Wei Wang, Weixun Chen, Pran K. Datta, Ming‐Zhi Zhang, Bixiang Zhang, Xiaoping Chen	2013	60
6	Development and validation of a CIMP-associated prognostic model for hepatocellular carcinoma EBioMedicine ·Ganxun Li, Weiqi Xu, Lu Zhang, Tongtong Liu, Guan-nan Jin, Jia Song, Jingjing Wu, Yuwei Wang, Weixun Chen, Chuanhan Zhang, Xiaoping Chen, Zeyang Ding, Peng Zhu, Bixiang Zhang	2019	56
7	Understanding the versatile roles and applications of EpCAM in cancers: from bench to bedside Experimental Hematology and Oncology ·Yiyang Liu, Yufei Wang, Sheng Sun, Zeyu Chen, Shuai Xiang, Zeyang Ding, Zhao Huang, Bixiang Zhang	2022	55
8	Learning Curve in Robot-Assisted Laparoscopic Liver Resection Journal of Gastrointestinal Surgery ·Peng Zhu, Wei Liao, Zeyang Ding, Lin Chen, Wanguang Zhang, Bixiang Zhang, Xiaoping Chen	2018	52
9	H19 Promotes HCC Bone Metastasis Through Reducing Osteoprotegerin Expression in a Protein Phosphatase 1 Catalytic Subunit Alpha/p38 Mitogen‐Activated Protein Kinase–Dependent Manner and Sponging microRNA 200b‐3p Hepatology ·Zhao Huang, Liang Chu, Junnan Liang, Xiaolong Tan, Yu Wang, Jingyuan Wen, Jin Chen, Yu Wu, Sha Liu, Jingyu Liao, Rui Hou, Zeyang Ding, Zhanguo Zhang, Huifang Liang, Shasha Song, Caihong Yang, Jinming Zhang, Tao Guo, Xiaoping Chen, Bixiang Zhang	2020	52
10	Targeting transforming growth factor-β signaling for enhanced cancer chemotherapy Theranostics ·Jitang Chen, Zeyang Ding, Si Li, Sha Liu, Chen Xiao, Zifu Li, Bixiang Zhang, Xiaoping Chen, Xiangliang Yang	2020	48
11	MicroRNA-630 suppresses tumor metastasis through the TGF-β- miR-630-Slug signaling pathway and correlates inversely with poor prognosis in hepatocellular carcinoma Oncotarget ·Weixun Chen, Zhanguo Zhang, Zeyang Ding, Huifang Liang, Jia Song, Xiaolong Tan, Jingjing Wu, Guangzhen Li, Zhuo Zeng, Bixiang Zhang, Xiaoping Chen	2016	48
12	CENPA functions as a transcriptional regulator to promote hepatocellular carcinoma progression via cooperating with YY1 International Journal of Biological Sciences ·Jingyu Liao, Zeyu Chen, Ruizhi Chang, Tong Yuan, Ganxun Li, Chang Zhu, Jingyuan Wen, Wei Yi, Zhao Huang, Zeyang Ding, Liang Chu, Junnan Liang, Bixiang Zhang	2023	47
13	Non-coding small nucleolar RNA SNORD17 promotes the progression of hepatocellular carcinoma through a positive feedback loop upon p53 inactivation Cell Death and Differentiation ·Junnan Liang, Ganxun Li, Jingyu Liao, Zhao Huang, Jingyuan Wen, Yu Wang, Zeyu Chen, Guangzhen Cai, Weiqi Xu, Zeyang Ding, Huifang Liang, Pran K. Datta, Liang Chu, Xiaoping Chen, Bixiang Zhang	2022	43
14	The Roles of TIF1γ in Cancer Frontiers in Oncology ·Chengpeng Yu, Zeyang Ding, Huifang Liang, Bixiang Zhang, Xiaoping Chen	2019	42
15	Can Rational Combination of Ultra-high Dose Rate FLASH Radiotherapy with Immunotherapy Provide a Novel Approach to Cancer Treatment? Clinical Oncology ·Y. Zhang, Zeyang Ding, John P. Perentesis, Deepak Khuntia, SM Pfister, Ricky A. Sharma	2021	41
16	YTHDF2 Is a Therapeutic Target for HCC by Suppressing Immune Evasion and Angiogenesis Through ETV5/PD‐L1/VEGFA Axis Advanced Science ·Jingyuan Wen, Xue Lin, Wei Yi, Junnan Liang, Wenlong Jia, Tuying Yong, Liang Chu, Han Li, Shenqi Han, Jingyu Liao, Zeyu Chen, Yiyang Liu, Qiumeng Liu, Zeyang Ding, Huifang Liang, Lu Gan, Xiaoping Chen, Zhao Huang, Bixiang Zhang	2024	39
17	Significant response to anti-PD-1 based immunotherapy plus lenvatinib for recurrent intrahepatic cholangiocarcinoma with bone metastasis Medicine ·Weixun Chen, Ganxun Li, Zheng-nan Hu, Peng Zhu, Bixiang Zhang, Zeyang Ding	2019	37
18	Targeting MMP9 in CTNNB1 mutant hepatocellular carcinoma restores CD8 ⁺ T cell-mediated antitumour immunity and improves anti-PD-1 efficacy Gut ·Ning Cai, Kun Cheng, Yue Ma, Sha Liu, Ran Tao, Yani Li, Danfeng Li, Bin Guo, Wenlong Jia, Huifang Liang, Jianping Zhao, Limin Xia, Zeyang Ding, Jinhong Chen, Wanguang Zhang	2023	37
19	PTPRε Acts as a Metastatic Promoter in Hepatocellular Carcinoma by Facilitating Recruitment of SMAD3 to TGF‐β Receptor 1 Hepatology ·Zhibin Liao, Lin Chen, Xuewu Zhang, Hongwei Zhang, Xiaolong Tan, Keshuai Dong, Xun Lu, He Zhu, Qiumeng Liu, Zhanguo Zhang, Zeyang Ding, Wei Dong, Peng Zhu, Liang Chu, Huifang Liang, Pran K. Datta, Bixiang Zhang, Xiaoping Chen	2020	35
20	TRIM proteins in hepatocellular carcinoma Journal of Biomedical Science ·Kan Lu, Yonglong Pan, Zhao Huang, Huifang Liang, Zeyang Ding, Bixiang Zhang	2022	34

About Zeyang Ding

Zeyang Ding is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Surgery, having authored 92 papers that have together received 1.8k indexed citations. Recurring topics across this work include RNA modifications and cancer (14 papers), TGF-β signaling in diseases (10 papers), Liver physiology and pathology (8 papers), Cancer-related molecular mechanisms research (8 papers), Cancer Immunotherapy and Biomarkers (7 papers), Ferroptosis and cancer prognosis (7 papers), Epigenetics and DNA Methylation (7 papers) and Pancreatic and Hepatic Oncology Research (7 papers). The work is most often cited by research in Cancer Research (474 citations), Hepatology (192 citations), Biological Psychiatry (40 citations), Oncology (429 citations) and Molecular Biology (853 citations). Zeyang Ding has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Bixiang Zhang, Xiaoping Chen, Huifang Liang, Ganxun Li, Weixun Chen, Guan-nan Jin, Zhao Huang, Jia Song, Peng Zhu and Pran K. Datta. Their work appears in journals such as Aging, Hepatology, Frontiers in Immunology, Journal of Cellular Physiology and ACS Nano.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact